Trial ID or NCT#

NCT01293994

Status

recruiting iconRECRUITING

Purpose

The investigators will be collecting saliva DNA samples from chronic back pain patients. The investigators hope to find candidate genes associated with response to opioid medication by correlating molecular genetics data with pain measurement and opioid responsiveness data including opioid hyperalgesia and opioid analgesic tolerance.

Official Title

A Study of Genetic Variation Influencing Pain and Response to Opioid Medications in Patients With Chronic Pain

Eligibility Criteria

Ages Eligible for Study: 18 Years to 71 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Lawrence Chu, MD, MS
Lawrence Chu, MD, MS
Anesthesiologist
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Dan Hoang
(650) 887-4677